
TY  - JOUR
TI  - SUMMARY OF 2001 RSA ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 25
IS  - s5
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2001.tb05850.x
DO  - doi:10.1111/j.1530-0277.2001.tb05850.x
SP  - 6A
EP  - 153A
PY  - 2001
ER  - 

TY  - JOUR
TI  - Category Index
JO  - Hepatology
JA  - Hepatology
VL  - 70
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30943
DO  - doi:10.1002/hep.30943
SP  - 1463
EP  - 1476
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 47
IS  - S35
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.22682
DO  - doi:10.1002/ppul.22682
SP  - 223
EP  - 446
PY  - 2012
ER  - 

TY  - JOUR
TI  - RSA ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 30
IS  - s1
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2006.00151.x
DO  - doi:10.1111/j.1530-0277.2006.00151.x
SP  - 235A
EP  - 282A
PY  - 2006
ER  - 

TY  - JOUR
AU  - Gless, Judge Alan G.
TI  - Some post-Daubert trial tribulations of a simple country judge: Behavioral science evidence in trial courts
JO  - Behavioral Sciences & the Law
JA  - Behav. Sci. Law
VL  - 13
IS  - 2
SN  - 0735-3936
UR  - https://doi.org/10.1002/bsl.2370130207
DO  - doi:10.1002/bsl.2370130207
SP  - 261
EP  - 291
PY  - 1995
AB  - Abstract This article is written from the unique perspective of a rural trial court judge dealing with scientific evidence. It compares Frye and Daubert, finding them not so different in theory, once the general acceptance concept is properly understood. It notes the difficulty that Frye creates in the use of behavioral science evidence. It proposes applying Fryel/Daubert only to a Limited aspect of clinician testimony. The application of the expert evidence rules is discussed through the depiction of a trial in a rural juvenile court protective action, based loosely on an action tried to the author, followed by discussion of special jury trial considerations. This article concludes that junk science problems have not been created by faulty rules of evidence, but by faulty judicial performance and proposes an approach to a solution.
ER  - 

TY  - JOUR
TI  - Current Awareness
JO  - Yeast
JA  - Yeast
VL  - 17
IS  - 3
SN  - 0749-503X
UR  - https://doi.org/10.1002/1097-0061(20000930)17:3<255::AID-YEA9>3.0.CO;2-7
DO  - doi:10.1002/1097-0061(20000930)17:3<255::AID-YEA9>3.0.CO;2-7
SP  - 255
EP  - 262
PY  - 2000
AB  - Abstract In order to keep subscribers up-to-date with the latest developments in their field, this current awareness service is provided by John Wiley  2 General; 3 Large-scale sequencing and mapping; 4 Genome evolution; 5 Comparative genomics; 6 Gene families and regulons; 7 Pharmacogenomics; 8 Large-scale mutagenesis programmes; 9 Functional complementation; 10 Transcriptomics; 11 Proteomics; 12 Protein structural genomics; 13 Metabolomics; 14 Genomic approaches to development; 15 Technological advances; 16 Bioinformatics. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted
ER  - 

TY  - JOUR
TI  - 21st IEC Proceedings
JO  - Epilepsia
VL  - 36
IS  - s3
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1157.1995.tb01719.x
DO  - doi:10.1111/j.1528-1157.1995.tb01719.x
SP  - S1
EP  - S275
PY  - 1995
ER  - 

TY  - JOUR
TI  - American College of Clinical Pharmacy: Fourteenth Annual Meeting August 15–18, 1993 The Nugget Hotel Reno, Nevada
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 13
IS  - 3
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1993.tb02736.x
DO  - doi:10.1002/j.1875-9114.1993.tb02736.x
SP  - 267
EP  - 297
PY  - 1993
ER  - 

TY  - JOUR
TI  - Applications of Modeling & Simulation
JO  - Clinical Pharmacology in Drug Development
JA  - Clinical Pharmacology in Drug Development
VL  - 7
IS  - S1
SN  - 2160-763X
UR  - https://doi.org/10.1002/cpdd.610
DO  - doi:10.1002/cpdd.610
SP  - 1
EP  - 104
PY  - 2018
ER  - 

TY  - JOUR
C7  - 49
TI  - Annual Symposium of the Society for the Study of Inborn Errors of Metabolism
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 34
IS  - S3
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-011-9371-z
DO  - doi:10.1007/s10545-011-9371-z
SP  - 49
PY  - 2011
ER  - 

TY  - JOUR
TI  - Hemodialysis Abstracts from the 35th Annual Dialysis Conference 26th Annual Symposium on Pediatric Dialysis New Orleans, Louisiana January 31–February 3, 2015
JO  - Hemodialysis International
JA  - Hemodial Int
VL  - 19
IS  - 1
SN  - 1492-7535
UR  - https://doi.org/10.1111/hdi.12257
DO  - doi:10.1111/hdi.12257
SP  - 154
EP  - 196
PY  - 2015
ER  - 

AU  - Wetzel, Gayle Delmonte
C7  - pp. 125-188
TI  - Medical Applications of Recombinant Proteins in Humans and Animals
SN  - 9783527283156
UR  - https://doi.org/10.1002/9783527620869.ch5
DO  - doi:10.1002/9783527620869.ch5
SP  - 125-188
KW  - recombinant
KW  - therapeutic
KW  - infarction
KW  - mortality
KW  - transcription
PY  - 2015
AB  - Summary The prelims comprise: Introduction Human Medical Applications of Recombinant Proteins Applications in Animals Concluding Remarks
ER  - 

AU  - Wetzel, Gayle Delmonte
C7  - pp. 125-188
TI  - Medical Applications of Recombinant Proteins in Humans and Animals
SN  - 9783527257621
UR  - https://doi.org/10.1002/9783527620999.ch5d
DO  - doi:10.1002/9783527620999.ch5d
SP  - 125-188
KW  - recombinant
KW  - therapeutic
KW  - infarction
KW  - mortality
KW  - transcription
PY  - 2015
AB  - Summary The prelims comprise: Introduction Human Medical Applications of Recombinant Proteins Applications in Animals Concluding Remarks
ER  - 

TY  - JOUR
TI  - 41st Annual Meeting of the German–Speaking Mycological Society (DMykG)
JO  - Mycoses
VL  - 50
IS  - 5
SN  - 9783527257621
UR  - https://doi.org/10.1111/j.1439-0507.2007.01430_2.x
DO  - doi:10.1111/j.1439-0507.2007.01430_2.x
SP  - 334
EP  - 382
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 26
IS  - S2
SN  - 9783527257621
UR  - https://doi.org/10.1002/mds.23764
DO  - doi:10.1002/mds.23764
SP  - S1
EP  - S385
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 20
IS  - S1
SN  - 9783527257621
UR  - https://doi.org/10.1002/pds.2206
DO  - doi:10.1002/pds.2206
SP  - S1
EP  - S364
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts 1–204
JO  - Hepatology
JA  - Hepatology
VL  - 50
IS  - S4
SN  - 9783527257621
UR  - https://doi.org/10.1002/hep.23300
DO  - doi:10.1002/hep.23300
SP  - 302A
EP  - 401A
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Session 1: Gene Expression and Therapy; Health Care Delivery/Access/Quality
JO  - Hepatology
JA  - Hepatology
VL  - 62
IS  - S1
SN  - 9783527257621
UR  - https://doi.org/10.1002/hep.28213
DO  - doi:10.1002/hep.28213
SP  - 456A
EP  - 497A
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts from the Second Chinese Congress on Gerontology and Health Industry
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 61
IS  - s3
SN  - 9783527257621
UR  - https://doi.org/10.1111/jgs.12439
DO  - doi:10.1111/jgs.12439
SP  - S309
EP  - S362
PY  - 2013
ER  - 

TY  - JOUR
TI  - E-Poster Presentations (Oral) | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 9783527257621
UR  - https://doi.org/10.1111/jgh.14879
DO  - doi:10.1111/jgh.14879
SP  - 72
EP  - 582
PY  - 2019
ER  - 
